Influence of bifidobacterium on surgical site infection and enterobacterial flora in colorectal cancer surgery

Influence of bifidobacterium on surgical site infection and enterobacterial flora in colorectal cancer surgery - Influence of bifidobacterium on surgical site infection and enterobacterial flora in colorectal cancer surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003435

Enrollment

300

Registered

2010-04-02

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

polyethylene glycol-electrolyte sodium (2 L) polyethylene glycol-electrolyte sodium (2 L) oral antibiothics ()Kanamycin, metronidazol) polyethylene glycol-electrolyte sodium (2 L) oral Bifidoba

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who underwent elective colorecal cancer surgery

Exclusion criteria

Exclusion criteria: emergency surgery patients with acute inflammation

Design outcomes

Primary

Measure	Time frame
surgical site infection changes of enterobacterial flora	—

Secondary

Measure	Time frame
incidence of Clostridium difficile colitis	—

Countries

Japan

Contacts

Public ContactSotaro Sadahiro

Tokai University Department of Gastrointestinal Surgery

sadahiro@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026